218 related articles for article (PubMed ID: 15162445)
1. Allergen extracts directly mobilize and activate human eosinophils.
Svensson L; Rudin A; Wennerås C
Eur J Immunol; 2004 Jun; 34(6):1744-51. PubMed ID: 15162445
[TBL] [Abstract][Full Text] [Related]
2. Responsiveness of eosinophils to aeroallergens may be independent of atopic status.
Redvall E; Bengtsson U; Wennerås C
Scand J Immunol; 2008 Apr; 67(4):377-84. PubMed ID: 18282233
[TBL] [Abstract][Full Text] [Related]
3. House dust mite allergen activates human eosinophils via formyl peptide receptor and formyl peptide receptor-like 1.
Svensson L; Redvall E; Björn C; Karlsson J; Bergin AM; Rabiet MJ; Dahlgren C; Wennerås C
Eur J Immunol; 2007 Jul; 37(7):1966-77. PubMed ID: 17559171
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
5. Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators.
Plötz SG; Traidl-Hoffmann C; Feussner I; Kasche A; Feser A; Ring J; Jakob T; Behrendt H
J Allergy Clin Immunol; 2004 Jun; 113(6):1152-60. PubMed ID: 15208598
[TBL] [Abstract][Full Text] [Related]
6. [The roles of adhesion molecules, cytokines, and chemokines in eosinophil activation during allergic inflammation].
Chihara J
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():116-20. PubMed ID: 9216199
[TBL] [Abstract][Full Text] [Related]
7. The novel use of the human nasal epithelial cell line RPMI 2650 as an in vitro model to study the influence of allergens and cytokines on transforming growth factor-beta gene expression and protein release.
Salib RJ; Lau LC; Howarth PH
Clin Exp Allergy; 2005 Jun; 35(6):811-9. PubMed ID: 15969674
[TBL] [Abstract][Full Text] [Related]
8. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation.
Malm-Erjefält M; Greiff L; Ankerst J; Andersson M; Wallengren J; Cardell LO; Rak S; Persson CG; Erjefält JS
Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793
[TBL] [Abstract][Full Text] [Related]
9. Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions.
Piliponsky AM; Pickholtz D; Gleich GJ; Levi-Schaffer F
J Allergy Clin Immunol; 2001 Jun; 107(6):993-1000. PubMed ID: 11398076
[TBL] [Abstract][Full Text] [Related]
10. Human eosinophils express a receptor for secretory component. Role in secretory IgA-dependent activation.
Lamkhioued B; Gounni AS; Gruart V; Pierce A; Capron A; Capron M
Eur J Immunol; 1995 Jan; 25(1):117-25. PubMed ID: 7843220
[TBL] [Abstract][Full Text] [Related]
11. The non-proteolytic house dust mite allergen Der p 2 induce NF-kappaB and MAPK dependent activation of bronchial epithelial cells.
Osterlund C; Grönlund H; Polovic N; Sundström S; Gafvelin G; Bucht A
Clin Exp Allergy; 2009 Aug; 39(8):1199-208. PubMed ID: 19486032
[TBL] [Abstract][Full Text] [Related]
12. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
[TBL] [Abstract][Full Text] [Related]
13. Respiratory syncytial virus-infected pulmonary epithelial cells induce eosinophil degranulation by a CD18-mediated mechanism.
Olszewska-Pazdrak B; Pazdrak K; Ogra PL; Garofalo RP
J Immunol; 1998 May; 160(10):4889-95. PubMed ID: 9590236
[TBL] [Abstract][Full Text] [Related]
14. [Effect of eosinophil major basic protein on histamine release from nasal epithelial mast cells].
Xiao S; Okuda M
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1997 Aug; 32(4):201-4. PubMed ID: 10743163
[TBL] [Abstract][Full Text] [Related]
15. Expression of lacto-N-fucopentaose III (CD15)- and sialyl-Lewis X-bearing molecules and their functional properties in eosinophils from patients with the idiopathic hypereosinophilic syndrome.
Satoh T; Knowles A; Li MS; Sun L; Tooze JA; Zabucchi G; Spry CJ
Immunology; 1994 Oct; 83(2):313-8. PubMed ID: 7835953
[TBL] [Abstract][Full Text] [Related]
16. The performance of a component-based allergen-microarray in clinical practice.
Wöhrl S; Vigl K; Zehetmayer S; Hiller R; Jarisch R; Prinz M; Stingl G; Kopp T
Allergy; 2006 May; 61(5):633-9. PubMed ID: 16629796
[TBL] [Abstract][Full Text] [Related]
17. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
Tsuda S; Miyasato M
Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
[TBL] [Abstract][Full Text] [Related]
18. Effect of immunotherapy on eosinophil activation in pollen sensitive children.
Pronk-Admiraal CJ; Schilte PP; Bartels PC
Clin Lab; 2001; 47(5-6):231-8. PubMed ID: 11405601
[TBL] [Abstract][Full Text] [Related]
19. Immune regulation by CD4+CD25+ T cells and interleukin-10 in birch pollen-allergic patients and non-allergic controls.
Thunberg S; Akdis M; Akdis CA; Grönneberg R; Malmström V; Trollmo C; van Hage M; Gafvelin G
Clin Exp Allergy; 2007 Aug; 37(8):1127-36. PubMed ID: 17651141
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil cationic protein (ECP) is processed during secretion.
Woschnagg C; Rubin J; Venge P
J Immunol; 2009 Sep; 183(6):3949-54. PubMed ID: 19692640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
